<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37730543</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>Effect of genetic liability to migraine and its subtypes on breast cancer: a mendelian randomization study.</ArticleTitle><Pagination><StartPage>887</StartPage><MedlinePgn>887</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-023-11337-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The relationship between migraine and breast cancer risk has generated conflicting findings. We attempted to assess the association between migraine and breast cancer risk using Mendelian randomization (MR) analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We selected genetic instruments associated with migraine from a recently published genome-wide association studies (GWAS). Inverse variant weighted (IVW) analysis was adopted as the main method, and we also performed the weighted-median method and the MR&#x2012;Egger, MR pleiotropy residual sum and outlier (MR-PRESSO), and MR Robust Adjusted Profile Score (MR-RAPS) methods as supplements.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our MR suggested that any migraine (AM) was a risk factor for overall breast cancer (IVW: odds ratio (OR)&#x2009;=&#x2009;1.072, 95% confidence intervals (CI)&#x2009;=&#x2009;1.035-1.110, P&#x2009;=&#x2009;8.78&#x2009;&#xd7;&#x2009;10<sup>-&#x2009;5</sup>, false discovery rate (FDR)&#x2009;=&#x2009;7.36&#x2009;&#xd7;&#x2009;10<sup>-&#x2009;4</sup>) and estrogen receptor-positive (ER+) breast cancer (IVW: OR&#x2009;=&#x2009;1.066, 95% CI&#x2009;=&#x2009;1.023-1.111, P&#x2009;=&#x2009;0.0024; FDR&#x2009;=&#x2009;0.0108) but not estrogen receptor-negative (ER-) breast cancer. In its subtype analysis, women with a history of migraine without aura (MO) had an increased risk of ER- breast cancer (IVW: OR&#x2009;=&#x2009;1.089, 95% CI&#x2009;=&#x2009;1.019-1.163, P&#x2009;=&#x2009;0.0118, FDR&#x2009;=&#x2009;0.0354), and MO was suggestively associated with the risk of overall breast cancer (FDR&#x2009;&gt;&#x2009;0.05 and IVW P&#x2009;&lt;&#x2009;0.05). No significant heterogeneity or horizontal pleiotropy was found in the sensitivity analysis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggested that women with AM have an increased risk of overall breast cancer and ER&#x2009;+&#x2009;breast cancer. MO was suggestively associated with the risk of overall breast cancer and ER- breast cancer.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Fang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Zhihao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Breast Center, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Huijie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wanchun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, Sichuan, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Fuqing</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Thyroid Breast Surgery, Xi'an NO.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, Shaanxi, 710018, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Liqun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu, Sichuan, 610041, China. zouliqun1971@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019HXFH053</GrantID><Agency>Incubation Project, West China Hospital, Sichuan University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Any migraine</Keyword><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Mendelian randomization.</Keyword><Keyword MajorTopicYN="N">Migraine with aura</Keyword><Keyword MajorTopicYN="N">Migraine without aura</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37730543</ArticleId><ArticleId IdType="doi">10.1186/s12885-023-11337-9</ArticleId><ArticleId IdType="pii">10.1186/s12885-023-11337-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Smith LJ, Henderson JA, Abell CW, Bethea CL. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2004;29(11):2035&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">15199371</ArticleId><ArticleId IdType="doi">10.1038/sj.npp.1300510</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267(1):64&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1727198</ArticleId><ArticleId IdType="doi">10.1001/jama.1992.03480010072027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005;45(Suppl 1):3&#x2013;s13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4610.2005.4501001.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkman DN, Couturier EGM, El Bouziani A, Dahdal J, Neefs J, Woudstra J et al. Migraine and cardiovascular disease: what cardiologists should know. Eur Heart J. 2023.</Citation></Reference><Reference><Citation>Islamoska S, Hansen &#xc3;M, Wang HX, Garde AH, Andersen PK, Garde E, et al. Mid- to late-life migraine diagnoses and risk of dementia: a national register-based follow-up study. J Headache Pain. 2020;21(1):98.</Citation><ArticleIdList><ArticleId IdType="pubmed">32762715</ArticleId><ArticleId IdType="pmc">7410151</ArticleId><ArticleId IdType="doi">10.1186/s10194-020-01166-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Elser H, Skajaa N, Ehrenstein V, Fuglsang CH, Farkas DK, S&#xf8;rensen HT. Cancer risk in patients with migraine: a population-based cohort study in Denmark. Headache. 2022;62(1):57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">35041219</ArticleId><ArticleId IdType="doi">10.1111/head.14251</ArticleId></ArticleIdList></Reference><Reference><Citation>Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">25651787</ArticleId><ArticleId IdType="doi">10.3322/caac.21262</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, et al. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2030&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19589913</ArticleId><ArticleId IdType="pmc">2756173</ArticleId><ArticleId IdType="doi">10.1158/1055-9965.EPI-09-0291</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghorbani A, Moradi A, Gookizadeh A, Jokar S, Sonbolestan SA. Evaluation of relationship between breast cancer and migraine. Adv Biomed Res. 2015;4:14.</Citation><ArticleIdList><ArticleId IdType="pubmed">25625120</ArticleId><ArticleId IdType="pmc">4300591</ArticleId><ArticleId IdType="doi">10.4103/2277-9175.148297</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter AC, Rexrode KM, Lee IM, Buring JE, Tamimi RM, Kurth T. Migraine and subsequent risk of breast cancer: a prospective cohort study. Cancer Causes Control. 2013;24(1):81&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23143336</ArticleId><ArticleId IdType="doi">10.1007/s10552-012-0092-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter AC, Rice MS, Fortner RT, Eliassen AH, Kurth T, Tamimi RM. Migraine and breast cancer risk: a prospective cohort study and meta-analysis. J Natl Cancer Inst. 2015;107(1):381.</Citation><ArticleIdList><ArticleId IdType="pubmed">25505231</ArticleId><ArticleId IdType="doi">10.1093/jnci/dju381</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan CY, Lin CS, Huang WY, Lin KT, Chao HL, Tsao CC, et al. Association between migraine and breast Cancer risk: a Population-Based Cohort Study and Literature Review. J Womens Health (Larchmt). 2018;27(12):1499&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">30183462</ArticleId><ArticleId IdType="doi">10.1089/jwh.2018.6929</ArticleId></ArticleIdList></Reference><Reference><Citation>Badsha MB, Fu AQ. Learning causal Biological Networks with the Principle of mendelian randomization. Front Genet. 2019;10:460.</Citation><ArticleIdList><ArticleId IdType="pubmed">31164902</ArticleId><ArticleId IdType="pmc">6536645</ArticleId><ArticleId IdType="doi">10.3389/fgene.2019.00460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Fang T, Chen L, Qiu B, Lv Y. Thyroid function and COVID-19 susceptibility and its severity: a two-sample mendelian randomization study. Endocrinology. 2022;163(11).</Citation></Reference><Reference><Citation>Zhang Z, Fang T, Lv Y. Causal associations between thyroid dysfunction and COVID-19 susceptibility and severity: a bidirectional mendelian randomization study. Front Endocrinol (Lausanne). 2022;13:961717.</Citation><ArticleIdList><ArticleId IdType="pubmed">36147565</ArticleId><ArticleId IdType="doi">10.3389/fendo.2022.961717</ArticleId></ArticleIdList></Reference><Reference><Citation>Haycock PC, Burgess S, Wade KH, Bowden J, Relton C, Davey Smith G. Best (but oft-forgotten) practices: the design, analysis, and interpretation of mendelian randomization studies. Am J Clin Nutr. 2016;103(4):965&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">26961927</ArticleId><ArticleId IdType="pmc">4807699</ArticleId><ArticleId IdType="doi">10.3945/ajcn.115.118216</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow DI, Kuchenbaecker KB, Shah S, Sofat R, Holmes MV, White J, et al. Selecting instruments for mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol. 2016;45(5):1600&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">27342221</ArticleId><ArticleId IdType="pmc">5100611</ArticleId><ArticleId IdType="doi">10.1093/ije/dyw088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautakangas H, Winsvold BS, Ruotsalainen SE, Bjornsdottir G, Harder AVE, Kogelman LJA, et al. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet. 2022;54(2):152&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">35115687</ArticleId><ArticleId IdType="pmc">8837554</ArticleId><ArticleId IdType="doi">10.1038/s41588-021-00990-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">25064373</ArticleId><ArticleId IdType="pmc">4170722</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddu328</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe4;gi R, Morris AP. GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics. 2010;11:288.</Citation><ArticleIdList><ArticleId IdType="pubmed">20509871</ArticleId><ArticleId IdType="pmc">2893603</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-11-288</ArticleId></ArticleIdList></Reference><Reference><Citation>Michailidou K, Lindstr&#xf6;m S, Dennis J, Beesley J, Hui S, Kar S, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551(7678):92&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">29059683</ArticleId><ArticleId IdType="pmc">5798588</ArticleId><ArticleId IdType="doi">10.1038/nature24284</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">24114802</ArticleId><ArticleId IdType="pmc">4377079</ArticleId><ArticleId IdType="doi">10.1002/gepi.21758</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">12958120</ArticleId><ArticleId IdType="pmc">192859</ArticleId><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">26050253</ArticleId><ArticleId IdType="pmc">4469799</ArticleId><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid Instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">27061298</ArticleId><ArticleId IdType="pmc">4849733</ArticleId><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Chen Y, Wang J, Small DS. Powerful three-sample genome-wide design and robust statistical inference in summary-data mendelian randomization. Int J Epidemiol. 2019;48(5):1478&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">31298269</ArticleId><ArticleId IdType="doi">10.1093/ije/dyz142</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29686387</ArticleId><ArticleId IdType="pmc">6083837</ArticleId><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung CHC, Schooling CM. Systemic inflammatory regulators and risk of Alzheimer&#x2019;s disease: a bidirectional mendelian-randomization study. Int J Epidemiol. 2021;50(3):829&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">33313759</ArticleId><ArticleId IdType="doi">10.1093/ije/dyaa241</ArticleId></ArticleIdList></Reference><Reference><Citation>Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53(8):1278&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">23808666</ArticleId><ArticleId IdType="doi">10.1111/head.12150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesari E, Ahmadinezhad M, Arshadi M, Azizi H, Khodamoradi F. The association between migraine and breast cancer risk: a systematic review and meta-analysis. PLoS ONE. 2022;17(2):e0263628.</Citation><ArticleIdList><ArticleId IdType="pubmed">35143585</ArticleId><ArticleId IdType="pmc">8830615</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0263628</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy N, Desai MN, Schoenbrunner A, Schneeberger S, Janis JE. The complex relationship between estrogen and migraines: a scoping review. Syst Reviews. 2021;10(1):72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01618-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, et al. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3116&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">18990752</ArticleId><ArticleId IdType="pmc">2692343</ArticleId><ArticleId IdType="doi">10.1158/1055-9965.EPI-08-0527</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis. Br J Cancer. 2001;84(9):1188&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11336469</ArticleId><ArticleId IdType="pmc">2363879</ArticleId><ArticleId IdType="doi">10.1054/bjoc.2000.1709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer S, Linnebank M, Weller M, Bahmanyar S, Montgomery SM, Hillert J, et al. Cancer risk among patients with multiple sclerosis and their parents. Neurology. 2010;74(7):614&#x2013;5. author reply 5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20157167</ArticleId><ArticleId IdType="doi">10.1212/WNL.0b013e3181c777b7</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Deming-Halverson SL, Shrubsole MJ, Beeghly-Fadiel A, Cai H, Fair AM, et al. Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women. Breast Cancer Res Treat. 2014;146(2):439&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">24986698</ArticleId><ArticleId IdType="pmc">4130355</ArticleId><ArticleId IdType="doi">10.1007/s10549-014-3030-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, et al. Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010;28(6):1005&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">20100960</ArticleId><ArticleId IdType="pmc">2834426</ArticleId><ArticleId IdType="doi">10.1200/JCO.2009.25.0423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Wang M, Li S, Zhang Y. Migraine and breast cancer risk: a meta-analysis of observational studies based on MOOSE compliant. Medicine. 2016;95(30):e4031.</Citation><ArticleIdList><ArticleId IdType="pubmed">27472675</ArticleId><ArticleId IdType="pmc">5265812</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000004031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarker MA, Rahman M, Harun-Or-Rashid M, Hossain S, Kasuya H, Sakamoto J, et al. Association of smoked and smokeless tobacco use with migraine: a hospital-based case-control study in Dhaka, Bangladesh. Tob Induc Dis. 2013;11(1):15.</Citation><ArticleIdList><ArticleId IdType="pubmed">23826945</ArticleId><ArticleId IdType="pmc">3710238</ArticleId><ArticleId IdType="doi">10.1186/1617-9625-11-15</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimhanam C, Sangrajrang S, Ekpanyaskul C. Tobacco smoke exposure and breast cancer risk in thai urban females. Asian Pac J cancer Prevention: APJCP. 2014;15(17):7407&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2014.15.17.7407</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnesen S, Blanchard Z, Williams MM, Berrett KC, Li Z, Oesterreich S, et al. Estrogen receptor alpha mutations in breast Cancer cells cause gene expression changes through constant activity and secondary Effects. Cancer Res. 2021;81(3):539&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">33184109</ArticleId><ArticleId IdType="doi">10.1158/0008-5472.CAN-20-1171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv X, Xu B, Tang X, Liu S, Qian JH, Guo J, et al. The relationship between major depression and migraine: a bidirectional two-sample mendelian randomization study. Front Neurol. 2023;14:1143060.</Citation><ArticleIdList><ArticleId IdType="pubmed">37122299</ArticleId><ArticleId IdType="pmc">10140565</ArticleId><ArticleId IdType="doi">10.3389/fneur.2023.1143060</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu S, Wu Z, Wu Z, Wu J, Qian Y. Association between Insomnia and Migraine Risk: a case-control and bidirectional mendelian randomization study. Pharmgenomics Pers Med. 2021;14:971&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34413668</ArticleId><ArticleId IdType="pmc">8370591</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HP, Wei JC, Yip HT, Yeh MH. Association of Insomnia, Depressive Disorders, and Mood Disorders as risk factors with breast Cancer: a Nationwide Population-Based Cohort Study of 232,108 women in Taiwan. Front Oncol. 2021;11:757626.</Citation><ArticleIdList><ArticleId IdType="pubmed">34707998</ArticleId><ArticleId IdType="pmc">8542844</ArticleId><ArticleId IdType="doi">10.3389/fonc.2021.757626</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Bao H, Wang F, Yu L, Cong S, Zhou F, et al. Depressive symptoms and sleep duration as risk factors for breast Cancer - China, 2020. China CDC Wkly. 2023;5(15):333&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37193083</ArticleId><ArticleId IdType="pmc">10182911</ArticleId><ArticleId IdType="doi">10.46234/ccdcw2023.064</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohi K. Shared genetic correlation and causal association between major depressive disorder and breast cancer. BMC Med. 2023;21(1):203.</Citation><ArticleIdList><ArticleId IdType="pubmed">37280618</ArticleId><ArticleId IdType="pmc">10242811</ArticleId><ArticleId IdType="doi">10.1186/s12916-023-02905-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Farris SG, Thomas JG, Abrantes AM, Lipton RB, Burr EK, Godley FA, et al. Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraine. Cephalalgia. 2019;39(11):1465&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31260336</ArticleId><ArticleId IdType="doi">10.1177/0333102419861712</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon-Suen SC, Lewis SJ, Martin RM, English DR, Boyle T, Giles GG, et al. Physical activity, sedentary time and breast cancer risk: a mendelian randomisation study. Br J Sports Med. 2022;56(20):1157&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">36328784</ArticleId><ArticleId IdType="doi">10.1136/bjsports-2021-105132</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Fensom GK, Reeves GK, Key TJ. Physical activity and breast cancer risk: results from the UK Biobank prospective cohort. Br J Cancer. 2020;122(5):726&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">31919405</ArticleId><ArticleId IdType="pmc">7054300</ArticleId><ArticleId IdType="doi">10.1038/s41416-019-0700-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Lee J, Lee DW, Kim HR, Kang MY. Sedentary work and breast cancer risk: a systematic review and meta-analysis. J Occup Health. 2021;63(1):e12239.</Citation><ArticleIdList><ArticleId IdType="pubmed">34161650</ArticleId><ArticleId IdType="pmc">8221371</ArticleId><ArticleId IdType="doi">10.1002/1348-9585.12239</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>